InvestorsHub Logo
Followers 6
Posts 217
Boards Moderated 0
Alias Born 05/19/2004

Re: pymadams post# 1124

Monday, 12/10/2018 6:01:57 PM

Monday, December 10, 2018 6:01:57 PM

Post# of 1462

From Yahoo msg. board an hour ago.

Oppenheimer says: We are initiating coverage of BTX with an Outperform rating and $3.50 PT. .... We look to the Ophthalmology meeting in 1H19 as the next clinical catalyst.”

My questions:
1. When are Cohort 4 results to be reported?
2. Is there a Cohort 5 after that?
3. Could the next catalyst really be the AST RMAT meeting or final reports due in 1Q19?

TIA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTX News